Co-Diagnostics, Inc. Common Stock (CODX) — Cash Flow Reinvestment Rate
Co-Diagnostics, Inc. Common Stock (CODX) has a Cash Flow Reinvestment Rate of 4.65x as of September 2022, reinvesting $5.20 Million (capex $230.05K plus investments $4.97 Million) from operating cash flow of $1.12 Million. Check CODX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Co-Diagnostics, Inc. Common Stock Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Co-Diagnostics, Inc. Common Stock across 3 annual periods. Explore Co-Diagnostics, Inc. Common Stock long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Co-Diagnostics, Inc. Common Stock (2020–2022)
Year-by-year capital reinvestment analysis for Co-Diagnostics, Inc. Common Stock. For live market cap and broader valuation context, see market value of Co-Diagnostics, Inc. Common Stock.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 8.86x | $58.17 Million | $6.57 Million | $1.43 Million | ▲ +8477.1% |
| 2021 | 0.10x | $4.24 Million | $41.08 Million | $669.46K | ▼ -55.9% |
| 2020 | 0.23x | $6.60 Million | $28.17 Million | $774.40K | — |